These data suggest that UBE2O is dysregulated in AD neurons, and an age-associated reduction in UBE2O may facilitate neuronal death in AD and indicate that increasing UBE2O expression in neurons may have a therapeutic potential for AD. Here, UBE2O is linked to Alzheimer disease.